California pays meth and cocaine patients gift cards for clean drug tests

Contingency management — giving people retail gift cards, usually worth under $30, in exchange for negative drug tests — dates to the 1980s and is the most effective known treatment for meth and cocaine addiction, for which no FDA-approved medication exists. Patients are tested regularly over several months; each negative result earns a gift card, and payouts grow with each test. Researchers found people are twice as likely to stop using meth or cocaine with gift cards than with traditional counseling; scientists hypothesize the immediate reward replaces the dopamine rush of using.

Yet providers dismissed it for decades — "this isn't treatment, this is just paying people not to use drugs," as UCLA psychology professor emeritus Rick Rawson recalled hearing — and fraud concerns stymied adoption. The setback that stuck was Medicaid: Rawson persuaded California health officials to fund a pilot in 2005, but federal health officials warned it ran afoul of rules against doctors luring patients and billing Medicaid for care they never provided, and the pilot shut down. "I'd pretty much given up," Rawson said.

Outside the Department of Veterans Affairs, which has offered contingency management since 2011, the treatment lay dormant for nearly a decade — until fentanyl in the drug supply began killing stimulant users and attitudes shifted. Within four years, several states funded programs with federal grants or court-ruling money from opioid manufacturers. California, where meth-involved overdose deaths have skyrocketed, asked the federal government to let it become the first state to pay for contingency management with Medicaid dollars.

The Biden administration greenlit the plan inside California's CalAIM package of non-traditional services. Under the program, launched in 2023, gift cards start at $10 per stimulant-free urine test and climb to $26.50; a patient who tests negative every time for six months can earn up to $599.

Reward the negative test itself: gift cards starting at $10 and climbing to $26.50 make abstinence pay immediately, replacing the drug's dopamine hit

Stimulant addiction had no medication, so the only evidence-based tool was behavioral: immediate positive reinforcement for clean tests.

Rewards arrive minutes after the test result, at the moment the brain registers the win — the same immediacy the drug provides.

Escalating payouts make each consecutive clean test worth more than the last, rewarding streaks rather than one-off compliance.

The blocker was billing, not evidence: Medicaid rules against fraud couldn't treat a cash-equivalent reward as care, until California won a first-in-nation exception.

Pay for the outcome, not the service: a reward that lands within minutes of the behavior you want can beat therapy that lands weeks later — if you can survive the 'this is bribery' objection.

California's program launched in 2023 as part of CalAIM, with payments up to $599 for six months of clean tests; it remains to be seen whether that is enough money to persuade people to quit. The Department of Veterans Affairs has run the same approach since 2011, and other states have funded programs through federal grants and opioid-litigation money.